{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:21:55Z","timestamp":1773235315449,"version":"3.50.1"},"reference-count":54,"publisher":"The Journal of Food and Drug Analysis (JFDA), Food and Drug Administration, Taiwan (TFDA)","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T00:00:00Z","timestamp":1534291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Chi-Mei Medical Center, Yong Kang, Tainan City, Taiwan","award":["CMFHT10503"],"award-info":[{"award-number":["CMFHT10503"]}]}],"content-domain":{"domain":["jfda-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Food and Drug Analysis"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jfda.2018.08.002","type":"journal-article","created":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T06:07:02Z","timestamp":1535090822000},"page":"355-364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Ubiquitin-protein ligase E3a (UBE3A) as a new biomarker of cardiac hypertrophy in cell models"],"prefix":"10.38212","volume":"27","author":[{"given":"Kai-Chun","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ting","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhih-Cherng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4522-584X","authenticated-orcid":false,"given":"Juei-Tang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Chia","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"25385","reference":[{"key":"10.1016\/j.jfda.2018.08.002_bib1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cbi.2008.12.012","article-title":"Cardioprotective effect of gallic acid on cardiac troponin-T, cardiac marker enzymes, lipid peroxidation products and antioxidants in experimentally induced myocardial infarction in Wistar rats","volume":"179","author":"Priscilla","year":"2009","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jfda.2018.08.002_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1152\/physrev.00027.2001","article-title":"The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction","volume":"82","author":"Glickman","year":"2002","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jfda.2018.08.002_bib3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/ehjci\/jev155","article-title":"Right ventricular remodelling induced by exercise training in competitive athletes","volume":"17","author":"D'Ascenzi","year":"2016","journal-title":"Eur Heart J Cardiovas Imag"},{"key":"10.1016\/j.jfda.2018.08.002_bib4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","article-title":"Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies","volume":"128","author":"Bernardo","year":"2010","journal-title":"Pharmacol Therapeut"},{"key":"10.1016\/j.jfda.2018.08.002_bib5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signalling pathways","volume":"7","author":"Heineke","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jfda.2018.08.002_bib6","first-page":"41","article-title":"Potential markers in cardiac hypertrophy?","volume":"23","author":"Malinowski","year":"2012","journal-title":"EJIFCC"},{"key":"10.1016\/j.jfda.2018.08.002_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1749-6632.2009.05100.x","article-title":"Return to the fetal gene program: a suggested metabolic link to gene expression in the heart","volume":"1188","author":"Taegtmeyer","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jfda.2018.08.002_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092903","article-title":"A systematic review of fetal genes as biomarkers of cardiac hypertrophy in rodent models of diabetes","volume":"9","author":"Cox","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jfda.2018.08.002_bib9","first-page":"14","article-title":"The function of ubiquitin protein ligase E3A and its roles in human diseases","volume":"1","author":"Zhou","year":"2015","journal-title":"JBMBR"},{"key":"10.1016\/j.jfda.2018.08.002_bib10","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1212\/01.wnl.0000192261.02023.b8","article-title":"The ubiquitin proteolytic system: from a vague idea, through basic mechanisms, and onto human diseases and drug targeting","volume":"66","author":"Ciechanover","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jfda.2018.08.002_bib11","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1172\/JCI31757","article-title":"Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins","volume":"117","author":"Li","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jfda.2018.08.002_bib12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature10726","article-title":"Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons","volume":"481","author":"Huang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jfda.2018.08.002_bib13","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1523\/JNEUROSCI.23-07-02634.2003","article-title":"Derangements of hippocampal calcium\/calmodulin-dependent protein kinase II in a mouse model for Angelman mental retardation syndrome","volume":"23","author":"Weeber","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.jfda.2018.08.002_bib14","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.cardiores.2006.05.026","article-title":"Calcineurin regulates NFAT-dependent iNOS expression and protection of cardiomyocytes: co-operation with Src tyrosine kinase","volume":"71","author":"Obasanjo-Blackshire","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jfda.2018.08.002_bib15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fphar.2014.00036","article-title":"Integrated mechanisms of CaMKII-dependent ventricular remodeling","volume":"5","author":"Kreusser","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jfda.2018.08.002_bib16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0092-8674(00)81573-1","article-title":"A calcineurin-dependent transcriptional pathway for cardiac hypertrophy","volume":"93","author":"Molkentin","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.jfda.2018.08.002_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12012-014-9264-0","article-title":"H2O 2 induces myocardial hypertrophy in H9c2 cells: a potential role of Ube3a","volume":"15","author":"Song","year":"2015","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.jfda.2018.08.002_bib18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1006\/jmcc.2002.1526","article-title":"Role of oxidative stress in myocardial hypertrophy and failure","volume":"34","author":"Sawyer","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jfda.2018.08.002_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fphar.2017.00018","article-title":"Novel sulfur metabolites of garlic attenuate cardiac hypertrophy and remodeling through induction of Na+\/K+-ATPase expression","volume":"8","author":"Khatua","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jfda.2018.08.002_bib20","article-title":"Molecular mechanisms regarding potassium bromate (KBrO3)-induced cardiac hypertrophy without apoptosis in H9c2 cells","volume":"9","author":"Kou","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jfda.2018.08.002_bib21","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/jphp.12522","article-title":"Tropisetron inhibits high glucose-induced calcineurin\/NFAT hypertrophic pathway in H9c2 myocardial cells","volume":"68","author":"Asadi","year":"2016","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.jfda.2018.08.002_bib22","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.ijcard.2012.03.077","article-title":"Isoproterenol induced hypertrophy and associated signaling pathways are modulated by somatostatin in H9c2 cells","volume":"167","author":"Somvanshi","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jfda.2018.08.002_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071364","article-title":"Ginsenoside Rh2 improves cardiac fibrosis via PPARdelta-STAT3 signaling in type 1-like diabetic rats","volume":"18","author":"Lo","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jfda.2018.08.002_bib24","doi-asserted-by":"crossref","first-page":"15445","DOI":"10.1074\/jbc.M112.340356","article-title":"Nuclear factor of activated T cells 1 (NFAT1)-induced permissive chromatin modification facilitates nuclear factor-kappaB (NF-kappaB)-mediated interleukin-9 (IL-9) transactivation","volume":"287","author":"Jash","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jfda.2018.08.002_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neulet.2014.09.008","article-title":"Signals for increase of mu-opioid receptor expression in muscle by hyperglycemia","volume":"582","author":"Yeh","year":"2014","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jfda.2018.08.002_bib26","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.cardiores.2004.04.002","article-title":"Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes","volume":"63","author":"Fiedler","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jfda.2018.08.002_bib27","doi-asserted-by":"crossref","first-page":"15239","DOI":"10.1074\/jbc.275.20.15239","article-title":"Ca2+\/calmodulin-dependent kinase II and calcineurin play critical roles in endothelin-1-induced cardiomyocyte hypertrophy","volume":"275","author":"Zhu","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jfda.2018.08.002_bib28","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1017\/erm.2012.8","article-title":"Calcineurin inhibitors and immunosuppression - a tale of two isoforms","volume":"14","author":"Williams","year":"2012","journal-title":"Expet Rev Mol Med"},{"key":"10.1016\/j.jfda.2018.08.002_bib29","doi-asserted-by":"crossref","first-page":"918","DOI":"10.5301\/jn.5000192","article-title":"FK506 alleviates proteinuria in rats with adriamycin-induced nephropathy by down-regulating TRPC6 and CaN expression","volume":"25","author":"Liu","year":"2012","journal-title":"J Nephrol"},{"key":"10.1016\/j.jfda.2018.08.002_bib30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1159\/000438658","article-title":"Insulin increases expression of TRPC6 channels in podocytes by a calcineurin-dependent pathway","volume":"38","author":"Xia","year":"2016","journal-title":"Cell Physiol Biochem : Int J Exp Cell Physiol Biochem Pharmacol"},{"key":"10.1016\/j.jfda.2018.08.002_bib31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.coph.2007.12.012","article-title":"Hydrogen peroxide as an endogenous mediator and exogenous tool in cardiovascular research: issues and considerations","volume":"8","author":"Schroder","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jfda.2018.08.002_bib32","first-page":"125","article-title":"The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in\u00a0vitro. In\u00a0vitro cellular & developmental biology","volume":"47","author":"Watkins","year":"2011","journal-title":"Animal"},{"key":"10.1016\/j.jfda.2018.08.002_bib33","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1042\/cs0950519","article-title":"Measurement and significance of circulating natriuretic peptides in cardiovascular disease","volume":"95","author":"Sagnella","year":"1998","journal-title":"Clin Sci"},{"key":"10.1016\/j.jfda.2018.08.002_bib34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/01.RES.0000109415.17511.18","article-title":"Calcineurin\/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy","volume":"94","author":"Wilkins","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.jfda.2018.08.002_bib35","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00109-014-1234-2","article-title":"High glucose enhances store-operated calcium entry by upregulating ORAI\/STIM via calcineurin-NFAT signalling","volume":"93","author":"Daskoulidou","year":"2015","journal-title":"J Mol Med"},{"key":"10.1016\/j.jfda.2018.08.002_bib36","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.bbamcr.2014.01.002","article-title":"Somatostatin receptor-2 negatively regulates beta-adrenergic receptor mediated Ca(2+) dependent signaling pathways in H9c2 cells","volume":"1843","author":"Somvanshi","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jfda.2018.08.002_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.yjmcc.2008.03.025","article-title":"Protein quality control and degradation in cardiomyocytes","volume":"45","author":"Wang","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jfda.2018.08.002_bib38","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/cvr\/cvp247","article-title":"The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy","volume":"85","author":"Carrier","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jfda.2018.08.002_bib39","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ncb0311-184","article-title":"Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress","volume":"13","author":"Tabas","year":"2011","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jfda.2018.08.002_bib40","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bbadis.2014.07.028","article-title":"The interplay between autophagy and the ubiquitin-proteasome system in cardiac proteotoxicity","volume":"1852","author":"Wang","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jfda.2018.08.002_bib41","doi-asserted-by":"crossref","first-page":"E473","DOI":"10.1152\/ajpendo.00467.2015","article-title":"Diabetic cardiomyopathy: role of the E3 ubiquitin ligase","volume":"310","author":"Bai","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jfda.2018.08.002_bib42","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jmb.2018.01.021","article-title":"Network analysis of UBE3A\/E6AP-associated proteins provides connections to several distinct cellular processes","volume":"430","author":"Martinez-Noel","year":"2018","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jfda.2018.08.002_bib43","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.bbadis.2016.07.002","article-title":"Cardiac ubiquitin ligases: their role in cardiac metabolism, autophagy, cardioprotection and therapeutic potential","volume":"1862","author":"Parry","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jfda.2018.08.002_bib44","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3892\/mmr.2013.1848","article-title":"Integration of microarray profiles associated with cardiomyopathy and the potential role of Ube3a in apoptosis","volume":"9","author":"Zhang","year":"2014","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jfda.2018.08.002_bib45","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1172\/JCI119452","article-title":"p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes","volume":"99","author":"Long","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jfda.2018.08.002_bib46","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.yjmcc.2016.11.013","article-title":"Cardiac proteasome functional insufficiency plays a pathogenic role in diabetic cardiomyopathy","volume":"102","author":"Li","year":"2017","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jfda.2018.08.002_bib47","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3889\/oamjms.2016.011","article-title":"Cardiac biomarkers and left ventricular hypertrophy in asymptomatic hemodialysis patients","volume":"4","author":"Koycheva","year":"2016","journal-title":"Open access Macedonian J Med Sci"},{"key":"10.1016\/j.jfda.2018.08.002_bib48","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000085585","article-title":"Persistent elevation of C-reactive protein may predict cardiac hypertrophy and dysfunction in patients maintained on hemodialysis","volume":"25","author":"Kim","year":"2005","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jfda.2018.08.002_bib49","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.vascn.2015.10.002","article-title":"Cross-laboratory analytical validation of the cardiac biomarker NT-proANP in rat","volume":"77","author":"Vinken","year":"2016","journal-title":"J Pharmacol Toxicol Meth"},{"key":"10.1016\/j.jfda.2018.08.002_bib50","first-page":"465","article-title":"Effect of a dialysis session on the prognostic values of NT-proBNP, troponins, endothelial damage and inflammation biomarkers","volume":"23","author":"Codognotto","year":"2010","journal-title":"J Nephrol"},{"key":"10.1016\/j.jfda.2018.08.002_bib51","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1177\/0192623316668276","article-title":"Cardiac hypertrophy working group of the predictive safety testing C. Evaluation of cardiac toxicity biomarkers in rats from different laboratories","volume":"44","author":"Kim","year":"2016","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.jfda.2018.08.002_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005854","article-title":"Predictive model identifies key network regulators of cardiomyocyte mechano-signaling","volume":"13","author":"Tan","year":"2017","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.jfda.2018.08.002_bib53","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/01.RES.0000215985.18538.c4","article-title":"Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability","volume":"98","author":"Oka","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.jfda.2018.08.002_bib54","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/ajmg.b.32103","article-title":"Gene expression changes in peripheral blood from Chinese Han patients with Tourette syndrome","volume":"159B","author":"Lei","year":"2012","journal-title":"Am J Med Genet B, Neuropsychiatr Genet : Offic Publ Int Soc Psychiatr Genet"}],"container-title":["Journal of Food and Drug Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S102194981830125X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S102194981830125X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S102194981830125X?httpAccept=text\/plain","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T18:19:39Z","timestamp":1666635579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S102194981830125X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S102194981830125X"],"URL":"https:\/\/doi.org\/10.1016\/j.jfda.2018.08.002","relation":{},"ISSN":["1021-9498"],"issn-type":[{"value":"1021-9498","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ubiquitin-protein ligase E3a (UBE3A) as a new biomarker of cardiac hypertrophy in cell models","name":"articletitle","label":"Article Title"},{"value":"Journal of Food and Drug Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfda.2018.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Food and Drug Administration, Taiwan. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}